References - Homocysteine in Protein Structure/Function and Human Disease - page 146

302. Beltowski J, Wojcicka G, Jakubowski H. Modulation of paraoxonase 1 and protein
N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the
rat. J Endocrinol. 2010;204(2):191-8.
303. Ishimine N, Usami Y, Nogi S, Sumida T, Kurihara Y, Matsuda K, et al. Identification of
N-homocysteinylated apolipoprotein AI in normal human serum. Ann Clin Biochem.
2010;47(Pt 5):453-9.
304. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of plasma homocysteine by
the rat kidney in vivo. Atherosclerosis. 1995;116(1):59-62.
305. Gupta S, Kuhnisch J, Mustafa A, Lhotak S, Schlachterman A, Slifker MJ, et al. Mouse models
of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomo-
cysteinemia. FASEB J. 2009;23(3):883-93.
306. Rusek M, Jakubowski H. Cystathione beta synthase deficiency increases collagen
N-homocysteinylation in mice. Clin Chem Lab Med. 2012;50(2):A31.
307. Pexa A, Fischer K, Deussen A, Henle T. Homocysteine in food. Eur Food Res Technol.
2008;226:933-5.
308. Borowczyk K, Jakubowski H. N-Homocysteinylation causes hair keratin damage in humans
and animals. Clin Chem Lab Med. 2012;50(2):A52.
309. Robert K, Maurin N, Ledru A, Delabar J, Janel N. Hyperkeratosis in cystathionine beta
synthase-deficient mice: an animal model of hyperhomocysteinemia. Anat Rec A Discov Mol
Cell Evol Biol. 2004;280(2):1072-6.
310. Perla J, Undas A, Twardowski T, Jakubowski H. Purification of antibodies against
N-homocysteinylated proteins by affinity chromatography on Nomega-homocysteinyl-
aminohexyl-Agarose. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;807
(2):257-61.
311. Sibrian-Vazquez M, Escobedo JO, Lim S, Samoei GK, Strongin RM. Homocystamides
promote free-radical and oxidative damage to proteins. Proc Natl Acad Sci USA. 2010;107
(2):551-4.
312. Glowacki R, Bald E. Fully automated method for simultaneous determination of total
cysteine, cysteinylglycine, glutathione and homocysteine in plasma by HPLC with UV
absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877
(28):3400-4.
313. Mazur P, Kozynacka A, Durajski L, Glowacki R, Pfitzner R, Fijorek K, et al. Nvarepsilon-
homocysteinyl-lysine isopeptide is associated with progression of peripheral artery disease in
patients treated with folic acid. Eur J Vasc Endovasc Surg. 2012;43(5):588-93.
314. Kolarz M, Glowacki R, Stompor T, Wyroslak J, Undas A. Elevated levels of Nepsilon-
homocysteinyl-lysine isopeptide in patients on long-term hemodialysis. Clin Chem Lab Med.
2012;50(8):1373-8.
315. du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG. The synthesis of
oxytocin. J Am Chem Soc. 1954;76:3115-21.
316. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans.
Nature. 2005;435(7042):673-6.
317. Di Simplicio M, Massey-Chase R, Cowen PJ, Harmer CJ. Oxytocin enhances processing of
positive versus negative emotional information in healthy male volunteers. J

Psychopharmacol. 2009;23(3):241-8.
318. Jarvis D, Ferrier BM, Du Vigneaud V. The effect of increasing the size of the ring present in
deamino-oxytocin by one methylene group on its biological properties. The synthesis of 1-
gamma-mercaptobutyric acid-oxytocin. J Biol Chem. 1965;240(9):3553-7.
319. Hope DB, Du Vigneaud V. Synthesis of desamino-desoxyoxytocin, a biologically active
analogue of oxytocin. J Biol Chem. 1962;237:3146-50.
320. Ferretti G, Bacchetti T, Marotti E, Curatola G. Effect of homocysteinylation on human high-
density lipoproteins: a correlation with paraoxonase activity. Metabolism. 2003;52
(2):146-51.